Navigation Links
The Norma F. Pfriem International Fellowship in Hospice and Palliative Care Nursing
Date:4/17/2008

BRANFORD, Conn., April 17 /PRNewswire-USNewswire/ -- The Connecticut Hospice, Inc., the nation's 1st hospice, proudly announces the certification of 14 nurses from its first class of The Norma F. Pfriem International Fellowship in Hospice and Palliative Nursing. Funded by a generous grant merited by the Connecticut Hospice's long-standing reputation for its leadership as the premiere institute for education and training in hospice and palliative care. The Fellowship was established at the Connecticut Hospice state-of-the-art teaching institution, with its 52 bed inpatient hospice-hospital for adults and pediatrics and its complementary statewide hospice home care in 2005. This fifteen month intensive program focuses on principles of palliative care; interdisciplinary team approach to patient and family; core concepts of symptom management; and pharmacology. Hospice physicians and nurse practitioners, pharmacists, social workers and guest lecturers lead monthly interdisciplinary seminars followed by case studies and peer discussion. Clinical concepts are then applied in both the hospital and in homecare, with senior nurses serving as preceptors to the Fellows.

Professor Marilyn Harris, RN, MSN, CNAA, BC, FAAN and Editor of Health Care Administration and Honorary Chair of the of The Norma F. Pfriem International Fellowship in Hospice and Palliative Nursing states, "since it's founding in 2005, I have the opportunity to work with the administration, staff, and Fellows, participate in some of the educational programs, and celebrate the successful certification of the Fellows as Hospice and Palliative Care Nurses by the Hospice and Palliative Nurses Association. The patients and their families at The Connecticut Hospice are blessed to receive care and caring from the staff. The staff, in return, is blessed by the patients and families for whom they provide professional care at such an important time of their lives. It is my pleasure to offer congratulations to each Fellow who attained national recognition through the certification process." In June 2008 another group of 38 fellows complete the 15 month program and become eligible for national examination and certification.

Program director, Marianne Treantafilos, M.S.N., A.P.R.N. and Vice-President of Clinical Services, Sandy Klimas, R.N., B.S.N., M.P.H., share Professor Harris' enthusiasm at the success of the Fellowship. "The entire professional community at Connecticut Hospice has been enriched by participation in the Fellowship. Precepting and lecturing by the interdisciplinary team is in itself a means of learning, and engenders a spirit of renewed commitment to our organizational mission to provide quality of life, comfort and dignity to patients and families, based on the newest knowledge and provided by the most highly skilled professionals.

Most of all, the journey that each one of our patients and family are on, is made better by the knowledge and enhanced compassionate care that the staff may bring, following this program."


'/>"/>
SOURCE The Connecticut Hospice, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Clinical depression linked to abnormal emotional brain circuits
2. Brain imaging reveals breakdown of normal emotional processing
3. Normal role for schizophrenia risk gene identified
4. Novadaq Resumes Normal Business Operations by Securing ICG for SPY
5. How Candida albicans transforms from its normally benign form into life-threatening form
6. Grant Supports Study of Abnormal Ring-Shaped Chromosomes
7. How shyness and other normal human traits became sickness
8. Key Cleaning Solutions Products Utilized to Combat Community Acquired - MRSA (CA-MRSA) Are Succeeding In Killing Superbugs Where Normal Cleaning Practices and Products Are Not
9. Bad Children Can Happen to Good Parents: A Survival Manual for Parents of Difficult Children by Norman E. Hoffman, Ph.D.
10. Normal tissue not spared in new forms of breast cancer radiotherapy
11. Abnormal immune cells may cause unprovoked anaphylaxis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... Del. (PRWEB) , ... October 12, 2017 , ... ... and advisory services for healthcare compliance program management, will showcase a range of ... National Association for Assisted Living (NCAL) Convention and Expo to be held October ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... introduction of an innovative new design of the shoulder pad. The shoulder pad ... comfort while controlling your pain while using cold therapy. By utilizing ice and water ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... Hair Restoration, has recently contributed a medical article to the newly revamped ... Dr. Mohebi’s article spotlights the hair transplant procedure known as Follicular Unit ...
(Date:10/12/2017)... ... 12, 2017 , ... Women-owned and Grand Rapids-based workplace wellness ... in Wellness® by Best and Brightest. OnSite Wellness will be honored at the ... 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, located at ...
(Date:10/12/2017)... ... October 12, 2017 , ... Farm Forward ... and other leading institutions in announcing the launch of the Leadership Circle ... way animals are raised for food. , Founding members of the Leadership Circle ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), will ... and webcast on Friday, November 3, 2017, beginning at ... at approximately 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... financial performance and guidance for 2018, Hill-Rom executives will ... operational performance, and long-range financial outlook through 2020. ...
(Date:9/27/2017)... Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... its MyDario product is expected to appear on The Dr. Oz Show ... Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show kicked off ... The segment features ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology: